Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 1:25 AM
NCT ID:
NCT05675293
Eligibility Criteria:
Inclusion Criteria:
1. All patients have vaginal discharge.
2. All patients have irregular vaginal bleeding, especially after sexual intercourse.
3. All patients have dyspareunia.
4. All patients have Lower abdominal pain.
5. Group A: 20 women will receive oral medication (antibiotic zesrosin) and hot water with antiseptic.
6. Group B: 20 women will receive medication by iontophoresis (antibiotic ceftriaxone) and hot water with antiseptic.
Exclusion Criteria:
1. Patients with a history of hypersensitivity or adverse reactions associated with the delivered drug in (ceftriaxone).
2. Patients with prior medical histories of cardiac arrhythmias or hypercoagulability should not receive the procedure near cardiac pacemakers and superficial blood vessels.
3. In the vicinity of embedded wires, stapes, orthopedic implants, and areas of skin with lesions and impaired sensation.
4. It either should not be used or used with extreme caution during pregnancy.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
50 Years
Study:
NCT05675293
Study Brief:
Protocol Section:
NCT05675293